Literature DB >> 19615548

Gentian violet is safe.

Jack L Arbiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615548     DOI: 10.1016/j.jaad.2009.03.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Gentian violet: a 19th century drug re-emerges in the 21st century.

Authors:  Alexander M Maley; Jack L Arbiser
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

2.  Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma.

Authors:  Jingyi Chen; Fangxin Zhao; Hongxin Yang; Jianxun Wen; Ying Tang; Fang Wan; Xuan Zhang; Jianqiang Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

3.  Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis.

Authors:  M Yamaguchi; T Vikulina; J L Arbiser; M N Weitzmann
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

4.  Recurrent breast cellulitis from a nipple fissure.

Authors:  Matthew Alexander Pimentel; Anna K Haemel
Journal:  JAAD Case Rep       Date:  2018-03-02

5.  Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab.

Authors:  Sarah A Westergaard; Mary Jo Lechowicz; Maggie Harrington; Justin Elsey; Jack L Arbiser; Mohammad K Khan
Journal:  JAAD Case Rep       Date:  2020-06-04

6.  The Antibacterial Action of Safranin and Gentian Violet.

Authors:  Falah Al-Khikani; Aalae Ayit
Journal:  Rambam Maimonides Med J       Date:  2022-07-31

7.  Gentian violet induces wtp53 transactivation in cancer cells.

Authors:  Alessia Garufi; Valerio D'Orazi; Jack L Arbiser; Gabriella D'Orazi
Journal:  Int J Oncol       Date:  2014-02-14       Impact factor: 5.650

8.  Synergistic interactions of cadmium-free quantum dots embedded in a photosensitised polymer surface: efficient killing of multidrug-resistant strains at low ambient light levels.

Authors:  Ethel G A Owusu; Elnaz Yaghini; Imad Naasani; Ivan P Parkin; Elaine Allan; Alexander J MacRobert
Journal:  Nanoscale       Date:  2020-05-06       Impact factor: 7.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.